2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use.
OBJECTIVE
To determine the preference of members of the American Glaucoma Society for the use of antifibrotic agents (mitomycin C or 5-fluorouracil or both) and glaucoma drainage devices in ten clinical settings.


METHODS
Voluntary written survey of the American Glaucoma Society.


RESULTS
American Glaucoma Society (AGS) members continue to report preference for mitomycin C use in ten clinical settings. The percent usage for glaucoma drainage devices has increased in poor prognosis scenarios including the following: neovascular glaucoma, previous failed trabeculectomy, previous ECCE/ICCE, previous PKP, previous scleral buckling surgery, and uveitic glaucoma. However, trabeculectomy and MMC continue to be more likely employed for surgical management.


CONCLUSIONS
Despite the long-term complications of bleb-related infections, no statistically significant shift in preference away from MMC use or reduction in the concentration of drug delivery was observed since the 1996 survey.
Joshi
Anand B
AB
Department of Ophthalmology, University of Miami School of Medicine, Miami, Florida 33143, USA.
Parrish
Richard K
RK
Feuer
William F
WF
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004363:Drug Utilization / Q000706:statistics & numerical data; D005355:Fibrosis / Q000517:prevention & control; D018463:Filtering Surgery / Q000706:statistics & numerical data* / Q000639:trends; D005472:Fluorouracil / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy* / Q000601:surgery*; D020327:Glaucoma Drainage Implants / Q000706:statistics & numerical data; D006306:Health Surveys; D006801:Humans; D008511:Medicine / Q000706:statistics & numerical data; D016685:Mitomycin / Q000627:therapeutic use; D009885:Ophthalmology / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000639:trends*; D012955:Societies, Medical / Q000706:statistics & numerical data; D013038:Specialization; D014481:United States
D000970:Antineoplastic Agents; D016685:Mitomycin; D005472:Fluorouracil